Shares of Moderna rose by a staggering 31.93% in 30 days from $131.61 to $173.63 at 22:13 EST on Friday, following last session’s downward trend. NASDAQ Composite is rising 1.44% to $14,016.81, following last session’s upward trend,
Moderna’s last close was $168.10, 9.00% under its 52-week high of $189.26.
Moderna’s sales growth is 26009.7% for the present quarter and 6199.3% for the next. The company’s growth estimates for the current quarter and the next is 842.9% and 1948.4%, respectively.
Year-on-year quarterly revenue growth grew by 3960.8%, now sitting on 803.4M for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $173.63 at 22:13 EST, under its 52-week high of $189.26 and way higher than its 52-week low of $30.98.
Moderna’s Moving Average
Moderna’s worth is way above its 50-day moving average of $143.54 and way above its 200-day moving average of $119.02.
More news about Moderna.